ArticleAnnals of the rheumatic diseases2022

COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco

Milena Gianfrancesco et al.PubMed ↗Publisher ↗

No numbers read from the abstract.